610 related articles for article (PubMed ID: 31077304)
1. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
Trasanidou D; GerĂ³s AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
[TBL] [Abstract][Full Text] [Related]
2. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
Hwang S; Maxwell KL
CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
[TBL] [Abstract][Full Text] [Related]
3. The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.
Borges AL; Davidson AR; Bondy-Denomy J
Annu Rev Virol; 2017 Sep; 4(1):37-59. PubMed ID: 28749735
[TBL] [Abstract][Full Text] [Related]
4. Anti-CRISPR: discovery, mechanism and function.
Pawluk A; Davidson AR; Maxwell KL
Nat Rev Microbiol; 2018 Jan; 16(1):12-17. PubMed ID: 29062071
[TBL] [Abstract][Full Text] [Related]
5. Phage-Encoded Anti-CRISPR Defenses.
Stanley SY; Maxwell KL
Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
[TBL] [Abstract][Full Text] [Related]
6. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CRISPR-Cas systems by mobile genetic elements.
Sontheimer EJ; Davidson AR
Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
[TBL] [Abstract][Full Text] [Related]
8. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
Liu Q; Zhang H; Huang X
FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
[TBL] [Abstract][Full Text] [Related]
9. Anti-CRISPRs go viral: The infection biology of CRISPR-Cas inhibitors.
Li Y; Bondy-Denomy J
Cell Host Microbe; 2021 May; 29(5):704-714. PubMed ID: 33444542
[TBL] [Abstract][Full Text] [Related]
10. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.
Hwang S; Maxwell KL
J Mol Biol; 2023 Apr; 435(7):168041. PubMed ID: 36893938
[TBL] [Abstract][Full Text] [Related]
11. Phage Against the Machine: Discovery and Mechanism of Type V Anti-CRISPRs.
Marino ND
J Mol Biol; 2023 Apr; 435(7):168054. PubMed ID: 36934807
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
[TBL] [Abstract][Full Text] [Related]
13. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9.
Hynes AP; Rousseau GM; Lemay ML; Horvath P; Romero DA; Fremaux C; Moineau S
Nat Microbiol; 2017 Oct; 2(10):1374-1380. PubMed ID: 28785032
[TBL] [Abstract][Full Text] [Related]
14. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
[TBL] [Abstract][Full Text] [Related]
15. Type II anti-CRISPR proteins as a new tool for synthetic biology.
Zhang Y; Marchisio MA
RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
[TBL] [Abstract][Full Text] [Related]
16. In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.
Wiedenheft B
RNA Biol; 2013 May; 10(5):886-90. PubMed ID: 23392292
[TBL] [Abstract][Full Text] [Related]
17. Diversity of molecular mechanisms used by anti-CRISPR proteins: the tip of an iceberg?
Hardouin P; Goulet A
Biochem Soc Trans; 2020 Apr; 48(2):507-516. PubMed ID: 32196554
[TBL] [Abstract][Full Text] [Related]
18. Ecology and evolution of phages encoding anti-CRISPR proteins.
Pons BJ; van Houte S; Westra ER; Chevallereau A
J Mol Biol; 2023 Apr; 435(7):167974. PubMed ID: 36690071
[TBL] [Abstract][Full Text] [Related]
19. Deciphering and shaping bacterial diversity through CRISPR.
Briner AE; Barrangou R
Curr Opin Microbiol; 2016 Jun; 31():101-108. PubMed ID: 27045713
[TBL] [Abstract][Full Text] [Related]
20. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
Maniv I; Jiang W; Bikard D; Marraffini LA
J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]